November 2024
The global androgenetic alopecia market size was estimated at US$ 2.98 billion in 2023 and is projected to grow to US$ 7.31 billion by 2034, rising at a compound annual growth rate (CAGR) of 8.49% from 2024 to 2034. The demand for androgenetic alopecia is increasing due to growing unhealthy lifestyles and pollution, which is leading to severe hair loss.
Unlock Infinite Advantages: Subscribe to Annual Membership
An overreaction to androgens causes androgenetic alopecia, a genetically established condition. The gradual loss of the scalp's terminal hair at any point after puberty is the hallmark of this disorder, which affects up to 50% of both males and girls. The production and distribution of drugs and equipment for the treatment of androgenetic alopecia are linked to the androgenetic alopecia market. The most prevalent kind of baldness, androgenetic alopecia (AGA), is characterized by gradual hair loss. Although incidence rates vary, AGA can affect people of all races. Caucasians are thought to have the highest prevalence. Prevalence rates are around 30% for males in their 30s, 40% for men in their 40s, and 50% for men in their 50s in Caucasian populations.
Recent advancements in this field—including new medications, stem cell research, successful hair transplants, clinical trials, and a better understanding of genetics—indicate that a long-term solution to baldness may be imminent. Research on stem cells as a potential treatment for baldness is encouraging. In order to heal damaged tissue, these cells have the capacity to change into different types of cells within your body.
Physicians say that maintaining therapy effectiveness and patient satisfaction over the long term is a major difficulty in the treatment of androgenetic alopecia.
North America dominated the androgenetic alopecia market in 2023. motivated by the existence of important industry participants and the rising incidence of hair loss in the general public. Customers may spend on cutting-edge therapies, which are frequently more expensive, because of the region's high level of disposable income. Furthermore, a strong healthcare infrastructure that supports research and development encourages the creation of novel treatment solutions. North America's leading market position is further cemented by the fact that it remains a center for the most recent developments in hair loss treatments.
Asia Pacific is expected to grow at a significant rate during the forecast period. An increase in the prevalence of respiratory conditions, such as chronic respiratory illnesses and other dysfunctions, is the main factor driving this expansion and increasing the need for efficient respiratory care solutions. Additionally, continued advancements in healthcare infrastructure make it easier to obtain cutting-edge medical treatments, especially in the region's growing economies. Asia-Pacific is positioned as a major growth region throughout the projection period due to these reasons, as well as higher healthcare investments.
By gender, the male segment dominated the androgenetic alopecia market in 2023. By the age of 50, 30 to 50 percent of males suffer from male androgenetic alopecia (MAA), the most prevalent kind of hair loss in men. It is generally known that there is a family tendency to MAA and that the frequency varies by race, with genetics explaining around 80% of the risk.
By treatment, the pharmaceuticals segment held the largest share of the androgenetic alopecia market in 2023. The most often used treatments for this illness are minoxidil and 5-alpha reductase inhibitors, while there are other options as well.
By treatment, the devices segment is estimated to grow at the fastest rate during the predicted timeframe. FDA-approved laser hair growth devices are used in laser hair therapy, often known as low-level laser therapy or LLLT. There are many different sizes and types of laser hair treatment equipment. Devices such as a laser comb, brush cap, helmet, and hood that people may wear or apply to their heads have received FDA approval.
By end-use, the dermatology clinics segment dominated the androgenetic alopecia market in 2023. Medical clinics offer cutting-edge treatment facilities together with medical help. By providing hassle-free medical consultations, it has simplified patients' life. Let's learn more about the significance and advantages of medical centers in depth.
By end-use, the homecare settings segment is estimated to grow at the fastest rate during the forecast period. The visual aspects of telehealth allow patients to develop a relationship with health care professionals over time, and patients can experience a possible support system that may allow them to stay at home.
By sales channel, the prescription segment dominated the androgenetic alopecia market in 2023. More powerful pharmaceuticals that help treat moderate to severe health issues are prescription meds. These medications are necessary to maintain a person's long-term health.
By sales channel, the OTC segment is expected to grow at a significant rate during the forecast period. The FDA has concluded that the advantages of over-the-counter medications outweigh any potential dangers or adverse effects, and they are low in toxicity. For self-diagnosed diseases, these drugs are similarly simple to use. They are well-labeled with usage instructions, cautions, and directions. Compared to prescription drugs, they are frequently less effective.
Developing new medicines to cure androgenic alopecia (hair loss), which is thought to impact over 50 million men and over 30 million women in the US alone, is the primary goal of Amplifica, a biopharmaceutical business. The business has discovered and separated distinct signaling molecules that promote hair follicle growth. To assess the safety and effectiveness of its fundamental technology, Amplifica will start clinical studies and secure the necessary regulatory clearances.
By Gender
By Treatment
By End-use
By Sales Channel
By Region
November 2024
November 2024
November 2024
November 2024
Deepa has certified the degree of Master’s in Pharmacy in the Pharmaceutical Quality Assurance department from Dr D.Y. Patil College of Pharmacy. Her research is focused on the healthcare industry. She is the author or co-author of four Review Articles, which include Solid dispersion a strategic method for poorly soluble drugs and solubility improvement techniques for poorly soluble drugs, Herbal Drugs Used In Treatment Of Cataracts, Nano sponges And Their Application in Cancer Prevention and Ayurvedic Remedies of Peptic ulcer. She has also published a Research Article on the Formulation and Evaluation of Mucoadhesive Tablets of Miconazole cocrystal which was published in GIS Science Journal Volume 9 Issue 8. Her passion for secondary research and desire to take on the challenge of solving unresolved issues is making her flourish is the in the research sector.
Annual Access, Limitless Research! Unlock all market research reports with our annual subscription. Stay on top of market trends and crucial insights year-round!
2500+
Client Queries in 20235000+
Insights Published60+
Consulting Projects Per Year40+
Analysts